Literature DB >> 16081669

Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural.

Ning Chen1, Jennifer E Hudson, Piotr Walczak, Iwona Misiuta, Svitlana Garbuzova-Davis, Lixian Jiang, Juan Sanchez-Ramos, Paul R Sanberg, Tanja Zigova, Alison E Willing.   

Abstract

The mononuclear fraction from human umbilical cord blood (HUCB) contains a significant number of stem/progenitor cells that in theory could be come any cell in the body, including neurons. Taking into consideration that transdifferentiation would be a very rare event and also knowing that overlapping genetic programs for hematopoiesis and neuropoiesis exist, we undertook a characterization of the HUCB mononuclear fraction, including analysis of cellular subpopulations and their morphology, cell viability, proliferation, and expression of neural and hematopoietic antigens. Two cell populations were apparent-adherent and floating fractions. The adherent fraction was mainly lymphocytes (~53%) expressing hematopoietic antigens. Upon replate, the floating population had many cells that expressed stem cell antigens. More of the cells in this subfraction expressed neural proteins. Neurotrophin receptors trkB and trkC were present in both cell fractions, although expression was higher in the floating fraction. Our initial characterization suggests that a subpopulation of cells exists within the HUCB mononuclear fraction that seems to have the potential to become neural cells, which could then be used in the development of cell-based therapies for brain injuries and diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081669      PMCID: PMC2680124          DOI: 10.1634/stemcells.2004-0284

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  43 in total

1.  Screening for GALC to make neonatal diagnosis and initial neonatal stem cell treatment with umbilical cord blood.

Authors:  Patricia A Galvin-Parton
Journal:  Pediatr Transplant       Date:  2003-04

Review 2.  Growth factors and stem cells as treatments for stroke recovery.

Authors:  Kevin Cairns; Seth P Finklestein
Journal:  Phys Med Rehabil Clin N Am       Date:  2003-02       Impact factor: 1.784

3.  Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells.

Authors:  S Wislet-Gendebien; P Leprince; G Moonen; B Rogister
Journal:  J Cell Sci       Date:  2003-07-02       Impact factor: 5.285

4.  Intravenous versus intrastriatal cord blood administration in a rodent model of stroke.

Authors:  A E Willing; J Lixian; M Milliken; S Poulos; T Zigova; S Song; C Hart; J Sanchez-Ramos; P R Sanberg
Journal:  J Neurosci Res       Date:  2003-08-01       Impact factor: 4.164

5.  Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke.

Authors:  Alison E Willing; Martina Vendrame; Jennifer Mallery; C Jordan Cassady; Cyndy D Davis; Juan Sanchez-Ramos; Paul R Sanberg
Journal:  Cell Transplant       Date:  2003       Impact factor: 4.064

6.  Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues.

Authors:  Maurizio Pesce; Alessia Orlandi; Maria Grazia Iachininoto; Stefania Straino; Anna Rita Torella; Vania Rizzuti; Giulio Pompilio; Giuseppina Bonanno; Giovanni Scambia; Maurizio C Capogrossi
Journal:  Circ Res       Date:  2003-08-14       Impact factor: 17.367

7.  Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation.

Authors:  Svitlana Garbuzova-Davis; Alison E Willing; Tanja Zigova; Samuel Saporta; Eleanor B Justen; Jennifer C Lane; Jennifer E Hudson; Ning Chen; Cyndy D Davis; Paul R Sanberg
Journal:  J Hematother Stem Cell Res       Date:  2003-06

8.  Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior.

Authors:  Samuel Saporta; Jong-Joong Kim; Alison E Willing; Eugene S Fu; Cyndy D Davis; Paul R Sanberg
Journal:  J Hematother Stem Cell Res       Date:  2003-06

Review 9.  [Wiskott-Aldrich syndrome: the possibilities of diagnosis and treatment].

Authors:  Algirda Krisiukeniene; Brigita Sitkauskiene; Raimundas Sakalauskas
Journal:  Medicina (Kaunas)       Date:  2003       Impact factor: 2.430

10.  The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma.

Authors:  Christina Nassenstein; Armin Braun; Veit Johannes Erpenbeck; Marek Lommatzsch; Stephanie Schmidt; Norbert Krug; Werner Luttmann; Harald Renz; Johann Christian Virchow
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  35 in total

Review 1.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

2.  Ensheathing cell-conditioned medium directs the differentiation of human umbilical cord blood cells into aldynoglial phenotype cells.

Authors:  María Dolores Ponce-Regalado; Daniel Ortuño-Sahagún; Carlos Beas Zarate; Graciela Gudiño-Cabrera
Journal:  Hum Cell       Date:  2012-04-21       Impact factor: 4.174

3.  Trophic factor induction of human umbilical cord blood cells in vitro and in vivo.

Authors:  Ning Chen; Siddharth Kamath; Jennifer Newcomb; Jennifer Hudson; Svitlana Garbuzova-Davis; Paula Bickford; Cyndy Davis-Sanberg; Paul Sanberg; Tanja Zigova; Alison Willing
Journal:  J Neural Eng       Date:  2007-04-04       Impact factor: 5.379

Review 4.  The possible use of stem cells in regenerative medicine: dream or reality?

Authors:  Sabrina Ehnert; Matthias Glanemann; Andreas Schmitt; Stephan Vogt; Naama Shanny; Natascha C Nussler; Ulrich Stöckle; Andreas Nussler
Journal:  Langenbecks Arch Surg       Date:  2009-07-31       Impact factor: 3.445

Review 5.  An Overview on Human Umbilical Cord Blood Stem Cell-Based Alternative In Vitro Models for Developmental Neurotoxicity Assessment.

Authors:  Abhishek Kumar Singh; Mahendra Pratap Kashyap
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

Review 6.  Stem cell transplants at childbirth.

Authors:  Paul R Sanberg; Dong-Hyuk Park; Cesar V Borlongan
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

Review 7.  Treatment of multiple system atrophy - the past, present and future.

Authors:  Haiyan Yu; Xiaoling Yuan; Lifeng Liu; Tian Wang; Dianrong Gong
Journal:  Am J Clin Exp Immunol       Date:  2018-10-05

8.  Defective neuromuscular transmission in the SOD1 G93A transgenic mouse improves after administration of human umbilical cord blood cells.

Authors:  Nizar Souayah; K M Coakley; R Chen; Norman Ende; Joseph J McArdle
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 9.  Umbilical cord blood research: current and future perspectives.

Authors:  Jennifer D Newcomb; Paul R Sanberg; Stephen K Klasko; Alison E Willing
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

Review 10.  Cord blood stem cells: a review of potential neurological applications.

Authors:  David T Harris
Journal:  Stem Cell Rev       Date:  2008-08-05       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.